M A Saragoça

728 total citations
34 papers, 589 citations indexed

About

M A Saragoça is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M A Saragoça has authored 34 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M A Saragoça's work include Cardiac electrophysiology and arrhythmias (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Renin-Angiotensin System Studies (5 papers). M A Saragoça is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Blood Pressure and Hypertension Studies (7 papers) and Renin-Angiotensin System Studies (5 papers). M A Saragoça collaborates with scholars based in Brazil, United States and Argentina. M A Saragoça's co-authors include Robert C. Tarazi, S Sen, Artur Beltrame Ribeiro, Sérgio Antônio Draibe, Osvaldo Kohlmann, O L Ramos, Rogério Andrade Mulinari, H Ajzen, Oswaldo L. Ramos and Haralambos Gavras and has published in prestigious journals such as Hypertension, European Heart Journal and American Heart Journal.

In The Last Decade

M A Saragoça

33 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M A Saragoça Brazil 14 345 114 102 98 90 34 589
Meryem Tuncel United States 13 345 1.0× 226 2.0× 78 0.8× 96 1.0× 88 1.0× 13 728
F LEENEN Canada 14 437 1.3× 185 1.6× 71 0.7× 101 1.0× 30 0.3× 21 682
Yasuharu Aki Japan 14 148 0.4× 71 0.6× 68 0.7× 141 1.4× 82 0.9× 35 506
J. D. H. Slater United States 17 256 0.7× 204 1.8× 152 1.5× 134 1.4× 94 1.0× 44 840
R. H. Freeman United States 15 365 1.1× 134 1.2× 66 0.6× 153 1.6× 65 0.7× 28 600
K. M. McDonald United States 11 185 0.5× 57 0.5× 65 0.6× 95 1.0× 110 1.2× 14 514
Daniel Levitan United States 10 279 0.8× 142 1.2× 64 0.6× 61 0.6× 137 1.5× 21 660
de Champlain J Canada 9 239 0.7× 248 2.2× 93 0.9× 168 1.7× 89 1.0× 19 723
P Sassano France 15 330 1.0× 242 2.1× 117 1.1× 90 0.9× 39 0.4× 43 647
SE Kjeldsen Norway 13 454 1.3× 186 1.6× 96 0.9× 55 0.6× 63 0.7× 32 681

Countries citing papers authored by M A Saragoça

Since Specialization
Citations

This map shows the geographic impact of M A Saragoça's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Saragoça with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Saragoça more than expected).

Fields of papers citing papers by M A Saragoça

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M A Saragoça. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Saragoça. The network helps show where M A Saragoça may publish in the future.

Co-authorship network of co-authors of M A Saragoça

This figure shows the co-authorship network connecting the top 25 collaborators of M A Saragoça. A scholar is included among the top collaborators of M A Saragoça based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M A Saragoça. M A Saragoça is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neto, Turíbio Leite Barros, et al.. (1995). The influence of isotonic exercise on cardiac hypertrophy in arterial hypertension: impact on cardiac function and on the capacity for aerobic work. Comparative Biochemistry and Physiology Part A Physiology. 112(2). 313–320. 7 indexed citations
2.
Canziani, María Eugênia Fernandes, et al.. (1995). Hemodialysis Versus Continuous Ambulatory Peritoneal Dialysis: Effects on the Heart. Artificial Organs. 19(3). 241–244. 31 indexed citations
3.
Saragoça, M A, et al.. (1993). Parenteral Isradipine Reduces Blood Pressure in Hypertensive Crisis. American Journal of Hypertension. 6(3_Pt_2). 112S–114S. 5 indexed citations
4.
Almeida, Fernando Antônio de, et al.. (1993). [Fosinopril in a daily single dose in mild and moderate hypertension. Brazilian multicenter study].. PubMed. 60(3). 203–8. 1 indexed citations
5.
Saragoça, M A, et al.. (1992). Isradipine in the treatment of hypertensive crisis in ambulatory patients.. UNIFESP Institutional Repository (Universidade Federal de São Paulo). 19 Suppl 3. S76–8. 9 indexed citations
6.
Martinez, Eulógio E., Steven F. Horowitz, Mario Luiz Vieira Castiglioni, et al.. (1992). Lung and myocardial thallium-201 kinetics in resting patients with congestive heart failure: Correlation with pulmonary capillary wedge pressure. American Heart Journal. 123(2). 427–432. 18 indexed citations
7.
Saragoça, M A, et al.. (1991). Left Ventricular Hypertrophy as a Risk Factor for Arrhythmias in Hemodialysis Patients. Journal of Cardiovascular Pharmacology. 17(Supplement 2). S136–S138. 38 indexed citations
8.
Saragoça, M A, et al.. (1991). Reversal of Left Ventricular Hypertrophy Following Treatment of Hypertension with Isradipine. Journal of Cardiovascular Pharmacology. 18. S28–S30. 5 indexed citations
9.
Saragoça, M A, et al.. (1991). Reversal of Left Ventricular Hypertrophy Following Treatment of Hypertension with Isradipine. Journal of Cardiovascular Pharmacology. 18. S28–S30. 1 indexed citations
10.
Saragoça, M A, et al.. (1991). Dipyridamole-Thallium Tests Are Predictive of Severe Cardiac Arrhythmias in Patients with Left Ventricular Hypertrophy. Journal of Cardiovascular Pharmacology. 17(Supplement 2). S139–S140. 1 indexed citations
11.
Bravo, Elena, Fetnat M. Fouad-Tarazi, Gian Paolo Rossi, et al.. (1990). A reevaluation of the hemodynamics of pheochromocytoma.. Hypertension. 15(2_supplement). I128–31. 38 indexed citations
12.
Saragoça, M A, et al.. (1988). Pindolol, not propranolol, reverses cardiac hypertrophy in renal hypertensive rats.. Hypertension. 11(2_pt_2). I89–92. 1 indexed citations
13.
Zanella, Maria Teresa, M A Saragoça, Rogério Andrade Mulinari, et al.. (1984). Acute hemodynamic and humoral effects of metoclopramide on blood pressure control improvement in subjects with diabetic orthostatic hypotension. Clinical Pharmacology & Therapeutics. 36(6). 738–744. 11 indexed citations
14.
Saragoça, M A, et al.. (1983). Anteroventral third ventricle and renin-angiotensin system interaction in the two-kidney, one clip hypertensive rat.. Hypertension. 5(6_pt_3). V90–3. 11 indexed citations
15.
Saragoça, M A, et al.. (1983). Hemodynamic mechanism of blood pressure response to captopril in human malignant hypertension.. Hypertension. 5(2_pt_2). I53–8. 14 indexed citations
16.
Saragoça, M A, et al.. (1982). [Hypertensive crisis. Treatment with captopril after failure with a diuretic. Multicenter study].. PubMed. 38(5). 415–9. 2 indexed citations
17.
Saragoça, M A & Robert C. Tarazi. (1981). Left ventricular hypertrophy in rats with renovascular hypertension. Alterations in cardiac function and adrenergic responses.. Hypertension. 3(6_pt_2). II–171. 50 indexed citations
18.
Saragoça, M A & Robert C. Tarazi. (1981). Impaired cardiac contractile response to isoproterenol in the spontaneously hypertensive rat.. Hypertension. 3(3). 380–385. 71 indexed citations
19.
Ribeiro, Artur Beltrame, M A Saragoça, Maria Teresa Zanella, et al.. (1981). Hypertension and economic activities in São Paulo, Brazil.. Hypertension. 3(6_pt_2). II–233. 25 indexed citations
20.
Masur, Jandira, et al.. (1979). Alcohol consumption by patients of general hospitals: a neglected problem?. 25(9). 302–306. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026